PMC:7291971 / 22691-22893 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T509","span":{"begin":41,"end":50},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T510","span":{"begin":143,"end":152},"obj":"CHEBI:36357;CHEBI:36357"}],"text":"CoV nsp14 N7-MTase, we further tested 10 compounds in a dose-response assay (Table 2 , Supporting Information Fig. S2). The selection of these compounds was based on their percentage inhibition higher t"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T184","span":{"begin":31,"end":37},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T185","span":{"begin":54,"end":55},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T186","span":{"begin":115,"end":117},"obj":"http://purl.obolibrary.org/obo/CLO_0008922"},{"id":"T187","span":{"begin":115,"end":117},"obj":"http://purl.obolibrary.org/obo/CLO_0050052"}],"text":"CoV nsp14 N7-MTase, we further tested 10 compounds in a dose-response assay (Table 2 , Supporting Information Fig. S2). The selection of these compounds was based on their percentage inhibition higher t"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T402","span":{"begin":115,"end":117},"obj":"Chemical"}],"attributes":[{"id":"A402","pred":"chebi_id","subj":"T402","obj":"http://purl.obolibrary.org/obo/CHEBI_29387"}],"text":"CoV nsp14 N7-MTase, we further tested 10 compounds in a dose-response assay (Table 2 , Supporting Information Fig. S2). The selection of these compounds was based on their percentage inhibition higher t"}